Literature DB >> 33090401

Circ-PRMT5 stimulates migration in esophageal cancer by binding miR-203.

L-W Zhang1, B Wang, J-X Yang, H Yang.   

Abstract

OBJECTIVE: The study aimed to uncover the role of circ-PRMT5 in triggering the migratory ability of esophageal cancer by regulating microRNA-203 (miR-203) level. PATIENTS AND METHODS: Circ-PRMT5 levels in 56 matched esophageal cancer tissues and paracancerous ones were detected. The relationship between circ-PRMT5 level and clinical data of esophageal cancer patients was analyzed. Migratory abilities in TE-1 and OE33 cells influenced by circ-PRMT5 were evaluated by transwell and wound healing assay. Regulatory effect of circ-PRMT5 on miR-203 level, and the involvement of miR-203 in the development of esophageal cancer were determined through Dual-Luciferase reporter assay and rescue experiments.
RESULTS: Circ-PRMT5 was upregulated in esophageal cancer tissues and cell lines. The expression level of circ-PRMT5 was positively correlated to the rates of lymphatic metastasis and distant metastasis of esophageal cancer. Knockdown of circ-PRMT5 attenuated migratory abilities in TE-1 and OE33 cells. MiR-203 was verified to be the target gene binding circ-PRMT5, with a negative correlation between each other. Notably, miR-203 was responsible for the regulatory effect of circ-PRMT5 on migratory ability in esophageal cancer.
CONCLUSIONS: Circ-PRMT5 is positively correlated to the rates of lymphatic metastasis and distant metastasis of esophageal cancer. It promotes migratory ability in esophageal cancer by targeting miR-203.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33090401     DOI: 10.26355/eurrev_202010_23209

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  circFIG 4 drives the carcinogenesis and metastasis of esophagus cancer via the miR-493-5p/E2F3 axis.

Authors:  Zhen Huang; Chunyue Wang; Xin Zhao
Journal:  Thorac Cancer       Date:  2022-01-26       Impact factor: 3.500

2.  CircATIC inhibits esophageal carcinoma progression and promotes radiosensitivity by elevating RHCG through sponging miR-10-3p.

Authors:  Kai Zhang; Ruitai Fan; Deyao Zhao; Peipei Liu; Zheng Yang; Junqi Liu; Song Zhang; Shilei Rao; Yang Wang; Lixin Wan
Journal:  Thorac Cancer       Date:  2022-03-20       Impact factor: 3.500

3.  CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways.

Authors:  Giulia Gallerani; Tania Rossi; Martina Valgiusti; Davide Angeli; Pietro Fici; Sara De Fanti; Erika Bandini; Claudia Cocchi; Giovanni Luca Frassineti; Massimiliano Bonafè; Francesco Fabbri
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.